A5055041709- Acute Myeloid Leukemia Research
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Infections and bacterial resistance
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Acute Lymphoblastic Leukemia research
- Antifungal resistance and susceptibility
- Healthcare cost, quality, practices
- Retinoids in leukemia and cellular processes
- Cystic Fibrosis Research Advances
- Enterobacteriaceae and Cronobacter Research
- Polyomavirus and related diseases
- COVID-19 Impact on Reproduction
- Neutropenia and Cancer Infections
- Ocular Infections and Treatments
Gaziantep Children's Hospital
2019-2024
Sağlık Bilimleri Üniversitesi
2019-2022
Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 in highly immunosuppressed populations, such as patients hematological malignancies, is a point interest. We aimed analyze symptoms, complications, intensive care unit admissions, and mortality rates infected Turkey.In this multicenter study, we included 340 adult pediatric diagnosed from March November 2020....
Objectives: Patients with hematologic malignancies have a high risk of coronavirus disease 2019 (COVID-19) mortality. This study aimed to investigate the impact COVID-19 on mortality rates in patients various and determine factors associated all-cause Methods: A multi-center, observational retrospective analysis infected between July 2020 December 2021 was performed. Demographic data, clinical characteristics, laboratory parameters were recorded. grouped as non-survivors survivors. All-cause...
Background and Objectives: Acute myeloid leukemia myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS limited in number efficacy. This study aims to evaluate venetoclax-based therapies AML/MDS, focusing on overall survival recurrence-free rates, expand real-world data its use. Materials Methods: Clinical laboratory patients with aged 18≥ treated venetoclax between January 2019 July 2022 were included. Survival...
Aim:The aim of our study is to obtain data on the quality life (QoL) in Hodgkin lymphoma (HL) patients a representative sample general population Turkey with help EORTC QLQ-C30 and QLQ-HL27 questionnaires.Material Methods: A total 68 from seven different centers diagnosed HL between 2018-2020 were included study.The questionnaires answered cross-sectionally by patient under control physician participating study.Results: Out patients, 42.6% (n=29) female 57.4% (n=39) male.The ages ranged 18...
Lymphoma is seen as a highly treatable and curable malignancy with aggressive treatment methods. Efficacy often limited by toxicity many patients need alternative strategies they cannot tolerate existing high cytotoxic approaches. Our aim to compare BEAM [carmustine (BCNU), etoposide, cytarabine (ARA-C, cytosine arabinoside), melphalan] mitoxantrone-melphalan (Mx-Mel) regimens utilized in our diagnosis of lymphoma who underwent autologous stem cell transplantation (ASCT), demonstrate that...
The aim of this study is to assess the efficacy and safety ruxolitinib in patients with myelofibrosis.From 15 centers, 176 (53.4% male, 46.6% female) were retrospectively evaluated.The median age at initiation was 62 (28–87) 100 (56.8%) all diagnosed as PMF. Constitutional symptoms observed 84.7%. dose 30 mg (10–40). Dose change made 69 (39.2%) patients. Forty seven (35.6%) 20 (15.2%) 132 had hematological nonhematological adverse events, respectively. mean spleen sizes before after...